Inmolecule Nanotech (FRA:DC0) NonCurrent Deferred Liabilities: €0.00 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:DC0 Inmolecule Nanotech SA FRA:DC0
6 GF Score
Price €3.84
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech NonCurrent Deferred Liabilities?

Inmolecule Nanotech FRA:DC0 6 NonCurrent Deferred Liabilities is €0.00 Mil as of Dec. 2024. GuruFocus rates FRA:DC0 with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Inmolecule Nanotech's non-current deferred liabilities for the quarter that ended in Dec. 2024 was €0.00 Mil.

Inmolecule Nanotech NonCurrent Deferred Liabilities Related Terms

Inmolecule Nanotech NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech NonCurrent Deferred Liabilities Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
NonCurrent Deferred Liabilities
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
NonCurrent Deferred Liabilities 0.00 0.00
FRA:DC0
6GF Score
Inmolecule Nanotech SA FRA:DC0
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €0.00 Mil mean?
Inmolecule Nanotech (FRA:DC0) has a NonCurrent Deferred Liabilities of €0.00 Mil as of Dec. 2024. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's NonCurrent Deferred Liabilities too high?
Inmolecule Nanotech's current NonCurrent Deferred Liabilities is €0.00 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Inmolecule Nanotech's NonCurrent Deferred Liabilities of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current NonCurrent Deferred Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (FRA:DC0) has a current NonCurrent Deferred Liabilities of €0.00 Mil. The current NonCurrent Deferred Liabilities is €0.00 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Inmolecule Nanotech (FRA:DC0), the current NonCurrent Deferred Liabilities is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Other Exchanges MLINA:France
Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for FRA:DC0

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.84
Price